GOP Rep. Will Continue to Campaign Despite Being Indicted for Insider Trading
Rep. Chris Collins (R-NY) released a statement Wednesday explaining his decision to run for a fourth term for New York’s 27th Congressional District despite being indicted for insider trading charges in August.
“The stakes are too high to allow the radical left to take control of this seat in Congress,” he wrote. “Their agenda is clear. They want to reverse the recently enacted tax cuts, impose Canadian style healthcare, inflict new job killing regulations and impeach President Trump.
An Important Update pic.twitter.com/UHL1XNTKhw
— Chris Collins (@CollinsNY27) September 19, 2018
According to investigators, Collins tipped his son off about an Australian pharmaceutical company, Innate Immunotherapeutics, failing a clinical trial. Collins was the company’s largest shareholder and he, along with his son and other family members, were able to sell their stock in the company before it was affected. They were able to avoid losing $750,000.
I’ll help you get your name out there. #DebateNate https://t.co/P0zEQ2XUf1
— Nate McMurray for Congress (@Nate_McMurray) September 19, 2018
(Read more from “GOP Rep. Will Continue to Campaign Despite Being Indicted for Insider Trading” HERE)
Follow Joe Miller on Twitter HERE and Facebook HERE.
